Lastly, Xu and co-workers proved that 4 could be used to treat pancreatic cancer since it increased the expression of proapoptotic protein (Bax) and decreased antiapoptotic Bcl2 protein as well as cyclin D1, whose overexpression is often related to chemoresistance [109]. The gene discussed is BCL2; the disease is pancreatic neoplasm.